Mircera 50mcg/0.3ml Injection

Mircera 50mcg/0.3ml Injection offers precise clinical management for anemia in renal patients, provided by PakMeds with professional cold-chain home delivery.

Manufacturer	Roche Pharmaceuticals
Active Ingredients	Methoxy Polyethylene Glycol-epoetin Beta
Medicine Strength	50mcg/0.3ml
Number Per Pack	1 Pre-filled Syringe
Requires Prescription?	Yes
Generics	Continuous Erythropoietin Receptor Activator (CERA)

Mircera 50mcg/0.3ml Injection Ingredients and Usage

Mircera 50mcg is a biological agent used to treat anemia in adults with chronic kidney disease. This lower strength is often used for dose titration or for patients who require smaller maintenance doses to keep their hemoglobin levels within the target range. It is suitable for patients both on and off dialysis. PakMeds provides this essential renal therapy to ensure patients can manage their energy levels and overall health despite chronic kidney conditions.

How Does Mircera 50mcg/0.3ml Injection Work?

Mircera acts as a long-lasting activator of the erythropoietin receptor. It mimics the body's natural hormone, erythropoietin, which signals the bone marrow to create new red blood cells. Because of its large molecular size and PEGylation, it remains in the bloodstream longer and activates the receptors more consistently than standard epoetin. This leads to a steady increase in hemoglobin and red blood cell volume, reducing the need for blood transfusions and alleviating the symptoms of anemia such as fatigue and shortness of breath.

Mircera 50mcg/0.3ml Injection Side Effects

Common side effects include nasopharyngitis, cough, and musculoskeletal pain. Increased blood pressure is a frequent clinical observation. Some patients may experience procedural pain or constipation. If a sudden, stabbing, migraine-like headache occurs, seek medical help immediately.

List of Warnings:

• Monitor hemoglobin levels closely to avoid exceeding the target of 12 g/dL.
• Not indicated for the treatment of anemia in cancer patients.
• If Pure Red Cell Aplasia is suspected, the medication must be discontinued permanently.
• Ensure the patient is iron-replete before and during therapy to ensure maximum efficacy.

Mircera 50mcg/0.3ml Injection Storage Conditions

Keep Mircera 50mcg in its original packaging in a refrigerator (2°C to 8°C). Protect from light and avoid shaking the syringe vigorously. Ensure it is kept out of the reach of children and do not use if the solution is cloudy or contains particles.